4. Bertrand P., Poirier J., Oda T., Finch C. E. and Pasinetti G. M. (1995) Association of apolipoprotein E genotype with brain levels of apolipoprotein E and
apolipoprotein J (clusterin) in Alzheimer disease. Brain Res. molec. Brain Res. 33, 174–178.
5. Chapman S. and Michaelson D. M. (1998) Specific neurochemical derangements of brain projecting neurons in apolipoprotein E-deficient mice.
J. Neurochem. 70, 708–714.
6. Chen Y., Lomnitski L., Michaelson D. M. and Shohami E. (1997) Motor and cognitive deficits in apolipoprotein E-deficient mice after closed head injury.
Neuroscience 80, 1255–1262.
7. Crawley J. N., Belknap J. K., Collins A., Crabbe J. C., Frankel W., Henderson N., Hitzemann R. J., Maxson S. C., Miner L. L., Silva A. J., Wehner J. M.,
Wynshaw-Boris A. and Paylor R. (1997) Behavioral phenotypes of inbred mouse strains: implications and recommendations for molecular studies.
Psychopharmacology 132, 107–124.
8. Fisher A., Brandeis R., Chapman S., Pittel Z. and Michaelson D. M. (1998) M1 muscarinic agonist treatment reverses cognitive and cholinergic
impairments of apolipoprotein E-deficient mice. J. Neurochem. 70, 1991–1997.
9. Fonnum F. A. (1975) A rapid radiochemical method of the determination of choline acetyltransferase. J. Neurochem. 24, 402–409.
10. Franklin K. B. J. and Paxinos G. (1997) The Mouse Brain in Stereotaxic Coordinates. Academic, San Diego.
11. Giacobini E. (1990) The cholinergic system in Alzheimer's disease. Prog. Brain Res. 84, 321–332.
12. Gordon I., Grauer E., Genis I., Sehayek E. and Michaelson D. M. (1995) Memory deficits and cholinergic impairments in apolipoprotein E-deficient mice.
Neurosci. Lett. 199, 1–4.
13. Masliah E., Mallory M., Alford M., Ge N. and Mucke L. (1995) Abnormal synaptic regeneration in hAPP695 transgenic and APOE knockout mice. In
Research Advances in Alzheimer's Disease and Related Disorders (eds Iqbal K., Mortimer J. A., Winblad B. and Wisniewski H. M.), pp. 405–414. John
Wiley, New York.
14. Masliah E., Mallory M., Alford M., Veinbergs I. and Roses A. D. (1995) Apolipoprotein E role in maintaining the integrity of the ageing central nervous
system. In Apolipoprotein E and Alzheimer's Disease (ed. Roses A. D.), pp. 59–73. Springler, New York.
15. Masliah E., Mallory M., Ge N., Alford M., Veinbergs I. and Roses A. D. (1995) Neurodegeneration in the CNS of apoE-deficient mice. Expl Neurol. 136,
107–122.
16. Oitzl M. S., Mulder M., Lucassen P. J., Havekes L. M., Grootendorst J. and de-Kloet E. R. (1997) Severe learning deficits in apolipoprotein E-knockout
mice in a water maze task. Brain Res. 752, 189–196.
17. Pepeu G. and Pepeu I. M. (1994) Dysfunction of the brain cholinergic system during ageing and after lesions of the nucleus basalis of Meynert. J. neural
Transm. 44, 189–194.
18. Piedrahita J. A., Zhang S. H., Hagaman J. R., Oliver P. M. and Maeda N. (1992) Generation of mice carrying a mutant apolipoprotein E gene inactivated
by gene targeting in embryonic stem cells. Proc. natn. Acad. Sci. U.S.A. 89, 4471–4475.
19. Plump A. S., Smith J. D., Hayek T., Aalto-Setala K., Walsh A., Verstuyft J. G., Rubin E. M. and Breslow J. L. (1992) Severe hypercholesterolemia and
atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells. Cell 71, 343–353.
20. Poirier J. (1994) Apolipoprotein E in animal models of CNS injury and in Alzheimer's disease. Trends Neurosci. 17, 525–530.
21. Poirier J., Baccichet A., Dea D. and Gauthier S. (1993) Cholesterol synthesis and lipoprotein reuptake during synaptic remodelling in hippocampus in
adult rats. Neuroscience 55, 81–90.
22. Poirier J., Davignon J., Bouthillier D., Kogan S., Bertrand P. and Gauthier S. (1993) Apolipoprotein E polymorphism and Alzheimer's disease. Lancet
342, 697–699.
23. Sirvio J. (1999) Strategies that support declining cholinergic neurotransmission in Alzheimer's disease patients. Gerontology 45, 3–14.
24. Soininen H., Kosunen O., Helisalmi S., Mannermaa A., Paljarvi L., Talasniemi S., Ryyna ̈nen M. and Riekkinen P. Sr (1995) A severe loss of choline
acetyltransferase in the frontal cortex of Alzheimer patients carrying apolipoprotein epsilon 4 allele. Neurosci. Lett. 187, 79–82.
25. Sweeney J. E., Puttfarcken P. S. and Coyle J. T. (1989) Galanthamine, an acetylcholinesterase inhibitor: a time course of the effects on performance and
neurochemical parameters in mice. Pharmac. Biochem. Behav. 34, 129–137.
26. Sweeney J. E., Hohmann C. F., Moran T. H. and Coyle J. T. (1988) A long-acting cholinesterase inhibitor reverses spatial memory deficits in mice.
Pharmac. Biochem. Behav. 31, 141–147.
27. Whitehouse P. J., Price D. L., Struble R. G., Clark A. W., Coyle J. T. and DeLong R. M. (1982) Alzheimer's disease and senile dementia: loss of neurons
in the basal forebrain. Science 215, 1237–1239.
